Home

Longitude Capital Associates, L.P.

CIK 1430719 · last filed 2016-11-17

Longitude Capital Associates, L.P. is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2008. The most recent filing shows the insider sold $6.7M of CORT on Nov 17, 2016. Across all open-market trades the lifetime net is −$19.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.61B across reported positions. The firm reports its address in Menlo Park, CA. 24 SEC filings were submitted jointly with Longitude Capital Partners, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.61B

Companies

2

Total Filings

5

Lifetime Open-Market Net

-$19.60M

Filer Profile

Reported Address
800 EL CAMINO REAL
SUITE 220
MENLO PARK, CA 94025
Phone
(650) 854-5700
Related Filers
Longitude Capital Partners, LLC — 24 joint filings, latest 2017-12-12
Longitude Venture Partners L.P. — 24 joint filings, latest 2017-12-12
Bakker Juliet Tammenoms — 24 joint filings, latest 2017-12-12
PATRICK G ENRIGHT — 3 joint filings, latest 2017-12-12
Longitude Capital Partners II, LLC — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CORT 10%+ Owner 14,537,385 $110.82 $1.61B -$31.73M 4 2016-11-17
Esperion Therapeutics, Inc. (ESPR) Delisted 10%+ Owner 33,753 $3.18 $107.3K $12.13M 1 2013-07-01

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2016-11-17 CORT Sell (S) −699,388 -$6.68M EDGAR
2015-03-24 CORT Mixed +4,686,692 -$43 EDGAR
2013-07-01 Esperion Therapeutics, Inc. (ESPR) Delisted Mixed +7,737,584 $12.13M EDGAR
2010-04-23 CORT Mixed +3,426,576 $5.69M EDGAR
2008-11-13 CORT Grant (A) +1,397,700 $2.03M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.